Zobrazeno 1 - 10
of 53
pro vyhledávání: ''
Autor:
Pelin Ertan, Esra Nagehan Akyol Onder
Publikováno v:
Klinische Pädiatrie. 233:292-298
Familial Mediterranean fever (FMF) is the most seen monogenic periodic fever syndrome characterised by bouts of fever and serositis. It is known that subclinical inflammation (SI) can persist in the symptom-free period and lead to amyloidosis even un
Autor:
Mehmet Yekta Oncel, Sema Arayici, Fuat Emre Canpolat, Nurdan Uras, Serife Suna Oguz, Gülsüm Kadıoğlu Şimşek
Publikováno v:
Klinische Pädiatrie. 234:74-80
To compare the effectiveness of cycled lighting (CL) or continuous near darkness (CND) on weight in preterm infants.Total 147 infants with a gestational age 25-32 weeks and/or a birth weight 750-1500 g were included in the study. The infants were cla
Autor:
Brar Piening, Lars Garten, Ann Carolin Longardt, Christoph Bührer, K. Weizsäcker, Christof Dame
Publikováno v:
Klinische Pädiatrie. 232:203-209
The extensive use of antibiotics is reflected by an increasing prevalence of infections with multidrug-resistant bacteria, including third-generation cephalosporin-resistant bacteria (3GCRB). For neonatal intensive care units screening and enhanced b
Publikováno v:
Klinische Pädiatrie. 231:283-290
The purpose of the German HB99 trial (1999-2008) for hepatoblastoma (HB), was primarily to analyse the effect of high dose (HD) chemotherapy with carboplatin/etoposide (CE) in high risk (HR) patients with extended tumors, vessel involvement, extrahep
Publikováno v:
Klinische Pädiatrie. 232:331-333
IntroductionVincristine is at the core of many treatment protocols for childhood malignancies. The major dose-limiting side effect is vincristine-induced peripheral neuropathy (VIPN) which may cause morbidity and disrupt curative treatment. Several s
Autor:
Jochen G. Mainz, N. Beiersdorf, Tanja Groten, Ruth K. Michl, Uwe Schneider, Anke Jaudszus, Michael Lorenz
Publikováno v:
Klinische Pädiatrie. 231:271-273
Publikováno v:
Klinische Pädiatrie. 228:286-293
Survival rates have been excellent in patients treated for Hodgkin lymphoma (HL) during childhood and adolescence. Unfortunately, severe treatment related late effects have been observed. It was therefore an important aim of the cooperative pediatric
Autor:
S. Habbig, F. Körber, R. Ehren, J. Matthies, Bernd Hoppe, R. Volland, Christoph Hünseler, Lutz T. Weber
Publikováno v:
Klinische Pädiatrie. 228:181-188
Background: Shigatoxin-associated haemolytic uremic syndrome (STEC-HUS) is the most frequent cause of acute kidney injury in children worldwide. Extrarenal manifestations are the main determinants for both, short- and long-term prognosis of patients
Publikováno v:
Klinische Pädiatrie. 228:124-129
Background: Neuroblastoma is a rare malignant disease and patients with high-risk neuroblastoma have a poor prognosis. Retinoic acid has been shown to inhibit growth of human neuroblastoma cells and has been considered as a potential candidate for im
Autor:
C von Neuhoff, Norbert Graf, Michael Dworzak, M Zimmermann, B. Gruhn, Thomas Lehrnbecher, J. Stray, Dirk Reinhardt, Bernhard Kremens, Gudrun Fleischhack, J-P Bourquin, Ursula Creutzig, A von Stackelberg, T. Klingebiel
Publikováno v:
Klinische Pädiatrie. 227:116-122
BACKGROUND The outcome in children and adolescents with high-risk (HR) acute myeloid leukemia (AML) is still unsatisfactory. Therefore, in study AML-BFM 2004 we aimed to improve outcome of HR-patients by adding moderately dosed 2-Chloro-2-Deoxyadenos